MedTech Dive October 13, 2023
Nick Paul Taylor

The administration is ramping up production of medtech guidance, adding 18 draft documents to the list of priorities for the upcoming financial year.

Dive Brief:

  • The Food and Drug Administration is ramping up production of medtech guidance, adding 18 draft documents to the list of priorities for its 2024 financial year.
  • In 2022 and 2023, the FDA’s A-lists featured 10 and four draft documents, respectively. The plan for 2024 is more ambitious, with the administration aiming to draft 18 documents on topics such as artificial intelligence, cybersecurity, real-world evidence and pulse oximeters.
  • Five of the priority drafts were on the FDA’s B-list last year. The B-list for 2024 is relatively short, featuring two final guidance documents and one...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: AI (Artificial Intelligence), Cybersecurity, FDA, Govt Agencies, Medical Devices, Technology
Related Articles:
Who’s Leading the FDA’s AI Race? Top Medical Specialties and Companies to Watch
FDA issues flu vaccine recommendations: 5 respiratory updates
5 Digital Health Areas To Be Impacted By The FDA Layoffs
FDA Approves First Biosimilar to Omalizumab
Trump's Nominees to Run FDA, NIH Get Greenlighted by Senate Committee

Share This Article